ROSUVASTATIN

ROSUVASTATIN was reported 86576 times

ROSUVASTATIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SPIROMETRY ABNORMAL 140 0.2341
1 MITE ALLERGY 140 0.2137
2 MYCOTIC ALLERGY 154 0.1801
3 CATARRH 162 0.1792
4 STEROID DEPENDENCE 152 0.1731
5 HIGH DENSITY LIPOPROTEIN DECREASED 550 0.1650
6 LOW DENSITY LIPOPROTEIN DECREASED 226 0.1595
7 DUST ALLERGY 150 0.1529
8 CAROTID ARTERIOSCLEROSIS 143 0.1386
9 OBSTRUCTIVE SLEEP APNOEA SYNDROME 185 0.1268
10 CONJUNCTIVITIS ALLERGIC 181 0.1221
11 SEDATION COMPLICATION 302 0.1182
12 HYPERPARATHYROIDISM SECONDARY 291 0.1160
13 NASAL OEDEMA 199 0.1101
14 MYOGLOBIN BLOOD INCREASED 163 0.1065
15 NEPHROGENIC ANAEMIA 487 0.1050
16 LOW DENSITY LIPOPROTEIN INCREASED 807 0.1041
17 BURNS SECOND DEGREE 164 0.0934
18 BLOOD CHOLESTEROL DECREASED 173 0.0928
19 RHABDOMYOLYSIS 3854 0.0923
20 ESSENTIAL HYPERTENSION 161 0.0879
21 REBOUND ACID HYPERSECRETION 264 0.0872
22 MYOPATHY 753 0.0871
23 BLOOD PRESSURE SYSTOLIC ABNORMAL 213 0.0861
24 BLOOD CHOLESTEROL ABNORMAL 394 0.0852
25 CREATININE RENAL CLEARANCE DECREASED 339 0.0846
26 DYSLIPIDAEMIA 414 0.0814
27 BLOOD PRESSURE DIASTOLIC ABNORMAL 193 0.0758
28 CORONARY ARTERY OCCLUSION 949 0.0691
29 BRONCHIECTASIS 448 0.0664
30 BLOOD CHOLESTEROL INCREASED 3052 0.0654
31 NORMOCHROMIC NORMOCYTIC ANAEMIA 195 0.0648
32 CORONARY ARTERY STENOSIS 321 0.0638
33 BLOOD CREATINE PHOSPHOKINASE INCREASED 1822 0.0632
34 BLOOD TRIGLYCERIDES INCREASED 1118 0.0632
35 CAROTID ARTERY STENOSIS 220 0.0629
36 ARTERIAL OCCLUSIVE DISEASE 489 0.0622
37 EUGLYCAEMIC DIABETIC KETOACIDOSIS 255 0.0617
38 GASTROINTESTINAL HYPOMOTILITY 136 0.0603
39 CAROTID ARTERY OCCLUSION 220 0.0602
40 BRAIN NATRIURETIC PEPTIDE INCREASED 178 0.0577
41 CARDIAC FAILURE CHRONIC 246 0.0577
42 ARTERIOSCLEROSIS 542 0.0575
43 ARTERIOSCLEROSIS CORONARY ARTERY 379 0.0571
44 IMMUNE-MEDIATED MYOSITIS 157 0.0569
45 ANGINA UNSTABLE 368 0.0566
46 MUSCLE DISORDER 450 0.0555
47 DIASTOLIC DYSFUNCTION 169 0.0547
48 HYPOPNOEA 190 0.0547
49 MYALGIA 9259 0.0544
50 RALES 307 0.0528
51 DIABETIC NEUROPATHY 253 0.0510
52 OBSTRUCTIVE AIRWAYS DISORDER 556 0.0499
53 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 204 0.0499
54 END STAGE RENAL DISEASE 909 0.0498
55 FORCED EXPIRATORY VOLUME DECREASED 137 0.0483
56 PLANTAR FASCIITIS 162 0.0483
57 HYPERCHOLESTEROLAEMIA 466 0.0482
58 TYPE 2 DIABETES MELLITUS 1624 0.0482
59 MUSCLE RUPTURE 187 0.0480
60 HYPERLIPIDAEMIA 571 0.0477
61 BLOOD PRESSURE SYSTOLIC INCREASED 914 0.0468
62 POLYMYALGIA RHEUMATICA 148 0.0465
63 BENIGN PROSTATIC HYPERPLASIA 240 0.0464
64 ORTHOSTATIC HYPOTENSION 801 0.0460
65 CHRONIC KIDNEY DISEASE 3480 0.0458
66 LEFT VENTRICULAR HYPERTROPHY 194 0.0453
67 VENTRICULAR HYPOKINESIA 144 0.0448
68 BUNDLE BRANCH BLOCK LEFT 188 0.0443
69 EXERCISE TOLERANCE DECREASED 255 0.0443
70 ANGINA PECTORIS 1265 0.0441
71 POTENTIATING DRUG INTERACTION 147 0.0438
72 CORONARY ARTERY DISEASE 1315 0.0434
73 FULL BLOOD COUNT ABNORMAL 450 0.0425
74 IMPAIRED GASTRIC EMPTYING 580 0.0425
75 BLOOD PRESSURE DIASTOLIC DECREASED 312 0.0422
76 SUPRAVENTRICULAR EXTRASYSTOLES 138 0.0408
77 MYOSITIS 363 0.0404
78 STENT PLACEMENT 325 0.0403
79 HAEMORRHAGIC ANAEMIA 175 0.0398
80 GLUCOSE TOLERANCE IMPAIRED 235 0.0397
81 TUBULOINTERSTITIAL NEPHRITIS 733 0.0391
82 BODY HEIGHT DECREASED 411 0.0384
83 GINGIVAL PAIN 305 0.0383
84 DIFFICULTY IN WALKING 131 0.0380
85 BREATH SOUNDS ABNORMAL 187 0.0379
86 ACUTE KIDNEY INJURY 5745 0.0375
87 RHINITIS 299 0.0370
88 BLOOD CALCIUM DECREASED 414 0.0368
89 PROSTATOMEGALY 144 0.0366
90 AORTIC STENOSIS 127 0.0364
91 RENAL TUBULAR NECROSIS 357 0.0364
92 MUSCLE ATROPHY 460 0.0363
93 MITRAL VALVE INCOMPETENCE 409 0.0361
94 CARDIAC MURMUR 312 0.0360
95 TROPONIN INCREASED 271 0.0356
96 BLOOD PRESSURE FLUCTUATION 848 0.0353
97 ACUTE MYOCARDIAL INFARCTION 1030 0.0349
98 PAROSMIA 263 0.0348
99 ACUTE CORONARY SYNDROME 286 0.0345
100 GLOMERULAR FILTRATION RATE DECREASED 423 0.0344
101 AORTIC VALVE INCOMPETENCE 146 0.0343
102 BODY TEMPERATURE DECREASED 333 0.0338
103 MUSCLE FATIGUE 143 0.0337
104 RED CELL DISTRIBUTION WIDTH INCREASED 139 0.0334
105 DIVERTICULUM INTESTINAL 146 0.0334
106 BLOOD CALCIUM INCREASED 292 0.0333
107 CORONARY ARTERIAL STENT INSERTION 166 0.0327
108 SPINAL STENOSIS 135 0.0327
109 PULMONARY ALVEOLAR HAEMORRHAGE 183 0.0326
110 BLOOD PRESSURE INADEQUATELY CONTROLLED 196 0.0325
111 CHROMATURIA 732 0.0324
112 URINE ABNORMALITY 147 0.0323
113 VITAMIN D DEFICIENCY 315 0.0323
114 TRICUSPID VALVE INCOMPETENCE 255 0.0321
115 VENTRICULAR EXTRASYSTOLES 332 0.0319
116 POLYP 208 0.0317
117 LEFT VENTRICULAR DYSFUNCTION 210 0.0313
118 HYPERTRIGLYCERIDAEMIA 183 0.0312
119 GASTROOESOPHAGEAL REFLUX DISEASE 2487 0.0309
120 DYSPNOEA EXERTIONAL 1163 0.0308
121 TENSION HEADACHE 131 0.0304
122 BLOOD PRESSURE DIASTOLIC INCREASED 140 0.0303
123 SPUTUM DISCOLOURED 287 0.0302
124 CORONARY ARTERY BYPASS 174 0.0302
125 AORTIC ANEURYSM 230 0.0302
126 WHEEZING 1773 0.0299
127 PERIPHERAL VASCULAR DISORDER 154 0.0299
128 DIVERTICULUM 212 0.0298
129 MUSCULAR WEAKNESS 3381 0.0297
130 MYOCARDIAL ISCHAEMIA 337 0.0296
131 COLITIS MICROSCOPIC 140 0.0295
132 RENAL FUNCTION TEST ABNORMAL 137 0.0295
133 BLOOD URIC ACID INCREASED 170 0.0294
134 MICTURITION URGENCY 336 0.0294
135 SLEEP APNOEA SYNDROME 561 0.0294
136 HEPATIC STEATOSIS 544 0.0292
137 CARDIOMYOPATHY 431 0.0291
138 BLOOD CREATINE INCREASED 129 0.0291
139 VITAMIN D DECREASED 249 0.0291
140 EJECTION FRACTION DECREASED 451 0.0290
141 HIATUS HERNIA 375 0.0289
142 NOCTURIA 351 0.0289
143 MUSCULOSKELETAL DISCOMFORT 497 0.0288
144 INTENTIONAL DRUG MISUSE 602 0.0288
145 HYPERKALAEMIA 1009 0.0287
146 MUSCLE SPASMS 5272 0.0287
147 DIABETES MELLITUS INADEQUATE CONTROL 506 0.0286
148 GOUT 512 0.0285
149 TRANSIENT ISCHAEMIC ATTACK 961 0.0285
150 DIABETES MELLITUS 2162 0.0283
151 BUNDLE BRANCH BLOCK RIGHT 130 0.0283
152 SPINAL COLUMN STENOSIS 132 0.0279
153 TENDON RUPTURE 345 0.0279
154 LACTIC ACIDOSIS 904 0.0279
155 HEPATIC ENZYME ABNORMAL 139 0.0278
156 EXOSTOSIS 254 0.0278
157 ELECTROCARDIOGRAM ABNORMAL 218 0.0278
158 LARGE INTESTINE POLYP 190 0.0274
159 TENDON DISORDER 178 0.0273
160 GLYCOSYLATED HAEMOGLOBIN INCREASED 687 0.0272
161 RENAL FAILURE 3609 0.0272
162 OSTEOARTHRITIS 1138 0.0268
163 DIZZINESS POSTURAL 259 0.0267
164 INTERVERTEBRAL DISC DEGENERATION 247 0.0267
165 EXTRASYSTOLES 186 0.0266
166 ANURIA 229 0.0266
167 ARTHRITIS 2085 0.0265
168 FLUSHING 2694 0.0265
169 HAEMORRHAGIC STROKE 206 0.0264
170 OEDEMA 1430 0.0263
171 RENAL CYST 209 0.0263
172 GUILLAIN-BARRE SYNDROME 127 0.0262
173 ROTATOR CUFF SYNDROME 335 0.0261
174 HEMIPLEGIA 217 0.0261
175 ATRIAL FIBRILLATION 2540 0.0261
176 THYROID DISORDER 402 0.0261
177 HAEMORRHOIDAL HAEMORRHAGE 127 0.0260
178 GROIN PAIN 228 0.0259
179 BLOOD URINE PRESENT 492 0.0259
180 PRODUCTIVE COUGH 1237 0.0259
181 ATRIAL FLUTTER 205 0.0257
182 CARDIOVASCULAR DISORDER 651 0.0256
183 POLLAKIURIA 1065 0.0255
184 INCREASED UPPER AIRWAY SECRETION 131 0.0255
185 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1329 0.0254
186 HEART RATE DECREASED 892 0.0254
187 CARDIAC FLUTTER 164 0.0253
188 PANCREATITIS ACUTE 570 0.0253
189 IMPAIRED QUALITY OF LIFE 364 0.0253
190 BLOOD CREATININE INCREASED 1653 0.0253
191 SPINAL OSTEOARTHRITIS 222 0.0252
192 PULMONARY MASS 376 0.0252
193 VASCULITIS 294 0.0252
194 NODULE 329 0.0252
195 BLOOD PRESSURE ABNORMAL 500 0.0251
196 MUSCLE INJURY 208 0.0251
197 HYPOMAGNESAEMIA 349 0.0250
198 LOWER GASTROINTESTINAL HAEMORRHAGE 185 0.0250
199 RESPIRATORY TRACT INFECTION 647 0.0248
200 URINE ODOUR ABNORMAL 146 0.0248
201 LIPASE INCREASED 190 0.0248
202 SENSORY LOSS 199 0.0247
203 SKIN LACERATION 267 0.0245
204 NEUROLOGICAL SYMPTOM 140 0.0245
205 BLOOD UREA INCREASED 410 0.0245
206 RENAL PAIN 259 0.0244
207 MULTIPLE ALLERGIES 191 0.0243
208 MYASTHENIA GRAVIS 196 0.0242
209 ASTHMA 2742 0.0242
210 GANGRENE 146 0.0242
211 HEPATOCELLULAR INJURY 343 0.0242
212 TENDONITIS 374 0.0241
213 BLOOD TESTOSTERONE DECREASED 165 0.0241
214 MYOCARDIAL INFARCTION 4208 0.0241
215 PAIN IN EXTREMITY 7094 0.0241
216 RENAL FAILURE CHRONIC 185 0.0240
217 FAECES DISCOLOURED 520 0.0240
218 POLYURIA 196 0.0239
219 ISCHAEMIC STROKE 427 0.0239
220 NEPHROPATHY 223 0.0239
221 HYPERGLYCAEMIA 868 0.0238
222 DIVERTICULITIS 659 0.0238
223 CARDIOMEGALY 292 0.0237
224 UPPER GASTROINTESTINAL HAEMORRHAGE 399 0.0237
225 RENAL FAILURE ACUTE 1002 0.0236
226 CARPAL TUNNEL SYNDROME 330 0.0235
227 DRUG INTERACTION 3734 0.0235
228 IRON DEFICIENCY ANAEMIA 216 0.0234
229 BLOOD PRESSURE INCREASED 3555 0.0232
230 TENDERNESS 242 0.0232
231 BLOOD TEST ABNORMAL 326 0.0232
232 METABOLIC ACIDOSIS 741 0.0231
233 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1110 0.0231
234 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 392 0.0231
235 MIDDLE INSOMNIA 431 0.0231
236 HAEMATURIA 790 0.0230
237 MUSCLE STRAIN 199 0.0230
238 DEFAECATION URGENCY 161 0.0230
239 CARDIAC FAILURE ACUTE 153 0.0229
240 INTERVERTEBRAL DISC PROTRUSION 501 0.0229
241 FREQUENT BOWEL MOVEMENTS 619 0.0229
242 HYPOVOLAEMIA 134 0.0229
243 SINUS CONGESTION 309 0.0228
244 BOWEL MOVEMENT IRREGULARITY 175 0.0228
245 OEDEMA PERIPHERAL 2772 0.0227
246 HYPOKINESIA 330 0.0227
247 HEARING IMPAIRED 136 0.0227
248 PULMONARY FIBROSIS 435 0.0227
249 BALANCE DISORDER 1959 0.0226
250 CATARACT 1348 0.0226
251 EOSINOPHILIA 396 0.0226
252 HAEMOPTYSIS 625 0.0224
253 OSTEOPENIA 340 0.0224
254 ATRIOVENTRICULAR BLOCK 173 0.0224
255 CONCOMITANT DISEASE AGGRAVATED 138 0.0223
256 DIABETIC KETOACIDOSIS 537 0.0223
257 URINE OUTPUT DECREASED 195 0.0223
258 SECRETION DISCHARGE 279 0.0223
259 SCIATICA 355 0.0222
260 NERVE COMPRESSION 205 0.0222
261 MUSCULOSKELETAL PAIN 1161 0.0221
262 CARDIAC PACEMAKER INSERTION 132 0.0221
263 VENTRICULAR TACHYCARDIA 365 0.0221
264 DYSPEPSIA 2165 0.0220
265 RECTAL HAEMORRHAGE 944 0.0220
266 INFUSION SITE SWELLING 138 0.0219
267 CHEST PAIN 4060 0.0219
268 CYSTITIS 698 0.0219
269 OSTEOPOROSIS 901 0.0219
270 FAECES SOFT 159 0.0218
271 SINUS DISORDER 432 0.0218
272 LIMB DISCOMFORT 670 0.0216
273 RENAL INJURY 643 0.0216
274 CONSTIPATION 4718 0.0216
275 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 191 0.0216
276 HEART RATE IRREGULAR 488 0.0216
277 AUTOIMMUNE HEPATITIS 150 0.0215
278 FLATULENCE 1223 0.0215
279 TINNITUS 989 0.0215
280 CARDIAC OPERATION 185 0.0215
281 EMPHYSEMA 217 0.0215
282 NECK PAIN 1199 0.0214
283 ALANINE AMINOTRANSFERASE INCREASED 1317 0.0214
284 SEASONAL ALLERGY 303 0.0214
285 RESTLESS LEGS SYNDROME 389 0.0214
286 LIVER INJURY 525 0.0214
287 LIVER FUNCTION TEST ABNORMAL 622 0.0214
288 TRANSAMINASES INCREASED 473 0.0213
289 ANAL INCONTINENCE 191 0.0212
290 RENAL IMPAIRMENT 1783 0.0212
291 INFARCTION 145 0.0212
292 HYPOTHYROIDISM 676 0.0211
293 BRAIN FOG 331 0.0211
294 BACK DISORDER 343 0.0211
295 COGNITIVE DISORDER 985 0.0211
296 ERUCTATION 408 0.0211
297 ERECTILE DYSFUNCTION 540 0.0210
298 HAEMORRHOIDS 408 0.0209
299 INTERNATIONAL NORMALISED RATIO INCREASED 596 0.0209
300 MELAENA 460 0.0209
301 HYPERTENSION 4426 0.0209
302 DECREASED ACTIVITY 225 0.0208
303 PRE-EXISTING CONDITION IMPROVED 130 0.0208
304 ASPARTATE AMINOTRANSFERASE INCREASED 1106 0.0208
305 EYE HAEMORRHAGE 277 0.0207
306 ECCHYMOSIS 142 0.0207
307 VENTRICULAR FIBRILLATION 230 0.0207
308 BURSITIS 251 0.0207
309 HOT FLUSH 1559 0.0207
310 PEMPHIGOID 156 0.0207
311 SENSATION OF FOREIGN BODY 174 0.0206
312 BLOOD MAGNESIUM DECREASED 178 0.0206
313 DUODENAL ULCER 145 0.0205
314 PROSTATIC SPECIFIC ANTIGEN INCREASED 283 0.0205
315 HYPOGLYCAEMIA 993 0.0205
316 PROTEINURIA 389 0.0204
317 ASTHENIA 7654 0.0203
318 HAEMATOCHEZIA 1123 0.0203
319 TENDON PAIN 154 0.0203
320 SUBDURAL HAEMATOMA 291 0.0203
321 DYSSTASIA 593 0.0203
322 FEELING HOT 1245 0.0203
323 CARDIAC FAILURE 1630 0.0203
324 BLOOD POTASSIUM INCREASED 329 0.0202
325 SUBARACHNOID HAEMORRHAGE 206 0.0202
326 NERVE INJURY 224 0.0201
327 LIMB INJURY 546 0.0201
328 JOINT INJURY 428 0.0200
329 GAIT DISTURBANCE 3832 0.0200
330 BLOOD POTASSIUM DECREASED 602 0.0200
331 ABNORMAL LOSS OF WEIGHT 136 0.0199
332 HYPERTRANSAMINASAEMIA 138 0.0198
333 RESPIRATORY RATE INCREASED 176 0.0198
334 CHEST DISCOMFORT 2020 0.0197
335 DYSURIA 726 0.0197
336 GLAUCOMA 379 0.0197
337 EOSINOPHIL COUNT INCREASED 164 0.0197
338 BACK PAIN 4566 0.0196
339 GASTRITIS 517 0.0196
340 WEIGHT DECREASED 5482 0.0196
341 HEPATIC ENZYME INCREASED 1338 0.0196
342 NEURALGIA 475 0.0195
343 CHOLESTASIS 375 0.0195
344 FACIAL PAIN 174 0.0195
345 PYELONEPHRITIS 168 0.0194
346 BLOOD IRON DECREASED 230 0.0194
347 VERTIGO 1181 0.0194
348 MOBILITY DECREASED 1392 0.0194
349 FALL 6436 0.0193
350 GASTRIC ULCER 367 0.0193
351 CEREBRAL INFARCTION 469 0.0192
352 DRUG-INDUCED LIVER INJURY 602 0.0192
353 BLOOD PRESSURE DECREASED 1274 0.0192
354 BASAL CELL CARCINOMA 299 0.0191
355 NIGHTMARE 663 0.0191
356 ARRHYTHMIA 907 0.0191
357 ATELECTASIS 185 0.0191
358 PRESYNCOPE 465 0.0191
359 COLITIS ISCHAEMIC 129 0.0191
360 SWOLLEN TONGUE 597 0.0191
361 LIGAMENT SPRAIN 189 0.0191
362 RENAL DISORDER 890 0.0191
363 DYSPHONIA 1117 0.0191
364 BLOOD ALBUMIN DECREASED 151 0.0190
365 SQUAMOUS CELL CARCINOMA 179 0.0190
366 PANCREATITIS 1005 0.0190
367 MUSCULOSKELETAL CHEST PAIN 294 0.0190
368 RED BLOOD CELL COUNT DECREASED 543 0.0190
369 FLANK PAIN 178 0.0190
370 DRY THROAT 193 0.0190
371 NEPHROLITHIASIS 870 0.0189
372 HEMIPARESIS 321 0.0189
373 LIVER FUNCTION TEST INCREASED 406 0.0189
374 CARDIAC DISORDER 1769 0.0189
375 BLOOD GLUCOSE FLUCTUATION 207 0.0189
376 DRY MOUTH 1532 0.0189
377 HAEMATOMA 489 0.0189
378 GAMMA-GLUTAMYLTRANSFERASE INCREASED 418 0.0188
379 WEIGHT FLUCTUATION 197 0.0188
380 IMPAIRED WORK ABILITY 402 0.0188
381 RIB FRACTURE 386 0.0187
382 BLOOD THYROID STIMULATING HORMONE INCREASED 172 0.0187
383 ARTHRALGIA 7767 0.0187
384 OXYGEN SATURATION DECREASED 1048 0.0186
385 INCREASED TENDENCY TO BRUISE 171 0.0186
386 APHASIA 561 0.0186
387 FOOT FRACTURE 352 0.0185
388 JOINT EFFUSION 128 0.0185
389 HYPOTENSION 3720 0.0185
390 BRONCHITIS 1372 0.0185
391 UROSEPSIS 171 0.0185
392 TOOTH INFECTION 244 0.0185
393 HAEMATOCRIT DECREASED 367 0.0185
394 AMNESIA 1204 0.0185
395 COORDINATION ABNORMAL 258 0.0185
396 BLADDER DISORDER 183 0.0184
397 COUGH 5159 0.0184
398 CHOLELITHIASIS 603 0.0184
399 HYPOXIA 646 0.0183
400 TASTE DISORDER 372 0.0183
401 SHOCK HAEMORRHAGIC 149 0.0183
402 MUSCULOSKELETAL STIFFNESS 1602 0.0183
403 TOOTH ABSCESS 186 0.0182
404 HYPERTHYROIDISM 264 0.0182
405 INTENTIONAL PRODUCT MISUSE 1591 0.0182
406 ABDOMINAL DISTENSION 1896 0.0181
407 THIRST 324 0.0181
408 PERIPHERAL COLDNESS 249 0.0181
409 CARDIOGENIC SHOCK 260 0.0181
410 HEAD INJURY 573 0.0181
411 DEHYDRATION 2415 0.0181
412 UPPER-AIRWAY COUGH SYNDROME 149 0.0181
413 RESPIRATORY TRACT CONGESTION 287 0.0180
414 TOOTH FRACTURE 199 0.0180
415 ANKLE FRACTURE 279 0.0180
416 PALPITATIONS 2106 0.0180
417 LIVER DISORDER 797 0.0180
418 INTERSTITIAL LUNG DISEASE 870 0.0179
419 MUSCLE TIGHTNESS 289 0.0178
420 INITIAL INSOMNIA 183 0.0178
421 HYPOPHAGIA 453 0.0177
422 PRODUCT ODOUR ABNORMAL 185 0.0176
423 SNEEZING 396 0.0176
424 FIBROMYALGIA 429 0.0176
425 SYNCOPE 1765 0.0176
426 HERNIA 341 0.0176
427 BURNING SENSATION 1235 0.0176
428 PELVIC FRACTURE 137 0.0176
429 SUPRAVENTRICULAR TACHYCARDIA 168 0.0175
430 DISEASE RECURRENCE 834 0.0175
431 MALNUTRITION 196 0.0175
432 POOR VENOUS ACCESS 181 0.0175
433 OROPHARYNGEAL DISCOMFORT 158 0.0175
434 ABASIA 432 0.0175
435 BACK INJURY 190 0.0175
436 MOTOR DYSFUNCTION 178 0.0174
437 SEDATION 457 0.0174
438 RED BLOOD CELL SEDIMENTATION RATE INCREASED 193 0.0174
439 EAR DISCOMFORT 179 0.0174
440 ASPIRATION 191 0.0174
441 CARDIAC FAILURE CONGESTIVE 1398 0.0174
442 TOOTHACHE 315 0.0174
443 DYSGEUSIA 1291 0.0174
444 CONTUSION 1670 0.0173
445 HYPOKALAEMIA 800 0.0173
446 DYSPNOEA 9810 0.0173
447 SPINAL PAIN 203 0.0173
448 BLOOD SODIUM DECREASED 326 0.0173
449 URINARY INCONTINENCE 512 0.0173
450 RHINORRHOEA 1116 0.0172
451 MACULAR DEGENERATION 206 0.0172
452 ABDOMINAL DISCOMFORT 2892 0.0172
453 CEREBRAL HAEMORRHAGE 616 0.0172
454 POOR QUALITY SLEEP 370 0.0172
455 PULMONARY CONGESTION 226 0.0171
456 SLEEP DISORDER 1207 0.0171
457 C-REACTIVE PROTEIN INCREASED 621 0.0171
458 OESOPHAGITIS 186 0.0170
459 AGEUSIA 424 0.0170
460 HEART RATE INCREASED 1676 0.0169
461 DRUG DOSE OMISSION 2795 0.0169
462 HEAD DISCOMFORT 299 0.0169
463 HYPONATRAEMIA 951 0.0169
464 PARAESTHESIA 2656 0.0169
465 GASTROINTESTINAL HAEMORRHAGE 1408 0.0168
466 APHONIA 235 0.0168
467 GASTROINTESTINAL PAIN 185 0.0168
468 MALIGNANT MELANOMA 225 0.0168
469 CELLULITIS 846 0.0168
470 BRADYCARDIA 890 0.0168
471 INFUSION SITE ERYTHEMA 141 0.0167
472 GASTROENTERITIS 244 0.0167
473 BLOOD ALKALINE PHOSPHATASE INCREASED 415 0.0167
474 DIPLOPIA 434 0.0167
475 ECONOMIC PROBLEM 253 0.0167
476 ABDOMINAL PAIN UPPER 3433 0.0167
477 LUNG DISORDER 817 0.0167
478 PHOTOSENSITIVITY REACTION 275 0.0166
479 NEUTROPHIL COUNT INCREASED 170 0.0166
480 FOOT DEFORMITY 184 0.0166
481 DIZZINESS 8274 0.0166
482 ACTIVITIES OF DAILY LIVING IMPAIRED 328 0.0165
483 EPISTAXIS 1237 0.0165
484 ACUTE RESPIRATORY FAILURE 318 0.0165
485 AFFECT LABILITY 159 0.0165
486 ABNORMAL FAECES 135 0.0165
487 JOINT SWELLING 1986 0.0164
488 CHOLECYSTITIS 196 0.0164
489 PHARYNGITIS 204 0.0164
490 PERIPHERAL SWELLING 2533 0.0164
491 URINARY TRACT INFECTION 2802 0.0164
492 CEREBROVASCULAR ACCIDENT 2781 0.0164
493 EAR PAIN 319 0.0164
494 BONE PAIN 961 0.0164
495 VITREOUS FLOATERS 161 0.0164
496 POST PROCEDURAL INFECTION 133 0.0163
497 BLOOD GLUCOSE INCREASED 3081 0.0163
498 CONFUSIONAL STATE 2641 0.0163
499 LOCALISED INFECTION 395 0.0163
500 HEPATITIS 417 0.0163
501 DECREASED APPETITE 3772 0.0162
502 FATIGUE 12643 0.0162
503 POST PROCEDURAL HAEMORRHAGE 189 0.0162
504 PULMONARY OEDEMA 727 0.0162
505 DRUG INTOLERANCE 1564 0.0162
506 WRIST FRACTURE 194 0.0162
507 JOINT DISLOCATION 171 0.0162
508 CLOSTRIDIUM DIFFICILE COLITIS 171 0.0161
509 POLYNEUROPATHY 193 0.0161
510 ANHEDONIA 423 0.0161
511 BLOOD GLUCOSE ABNORMAL 297 0.0161
512 OBESITY 256 0.0161
513 PNEUMONIA 5200 0.0160
514 EYELID PTOSIS 163 0.0160
515 EYE INFECTION 181 0.0160
516 GENERALISED OEDEMA 198 0.0160
517 ABDOMINAL PAIN 3714 0.0159
518 PURPURA 141 0.0159
519 PERICARDIAL EFFUSION 368 0.0159
520 JOINT STIFFNESS 417 0.0159
521 NIGHT SWEATS 512 0.0159
522 DEMENTIA 444 0.0159
523 OROPHARYNGEAL PAIN 1468 0.0158
524 COLITIS ULCERATIVE 708 0.0158
525 SINUSITIS 1623 0.0158
526 LACRIMATION INCREASED 478 0.0158
527 COVID-19 2769 0.0158
528 URINARY RETENTION 526 0.0157
529 BREAST PAIN 168 0.0157
530 PARAESTHESIA ORAL 227 0.0157
531 PETECHIAE 164 0.0157
532 FEBRILE NEUTROPENIA 1042 0.0157
533 NASAL CONGESTION 923 0.0157
534 MALAISE 6885 0.0157
535 HAIR COLOUR CHANGES 195 0.0157
536 UPPER RESPIRATORY TRACT INFECTION 724 0.0157
537 ABNORMAL DREAMS 432 0.0156
538 NEUROPATHY PERIPHERAL 1485 0.0156
539 MOVEMENT DISORDER 501 0.0156
540 UPPER LIMB FRACTURE 310 0.0155
541 HYPOAESTHESIA 2327 0.0155
542 ABDOMINAL PAIN LOWER 393 0.0155
543 INFLUENZA 1733 0.0155
544 DIARRHOEA 10009 0.0155
545 HYPERAESTHESIA 127 0.0154
546 SKIN ULCER 399 0.0154
547 FEELING COLD 428 0.0154
548 MEMORY IMPAIRMENT 2111 0.0153
549 GAIT INABILITY 513 0.0153
550 PLATELET COUNT INCREASED 200 0.0153
551 NASOPHARYNGITIS 2826 0.0153
552 PNEUMOTHORAX 243 0.0153
553 BLOOD COUNT ABNORMAL 232 0.0153
554 ARTHROPATHY 850 0.0153
555 HYPERHIDROSIS 1969 0.0153
556 LIP SWELLING 508 0.0152
557 INSOMNIA 4060 0.0152
558 DEPRESSED LEVEL OF CONSCIOUSNESS 601 0.0152
559 COELIAC DISEASE 149 0.0152
560 PLEURAL EFFUSION 921 0.0151
561 SPINAL FRACTURE 303 0.0151
562 CLOSTRIDIUM DIFFICILE INFECTION 330 0.0151
563 SCAB 172 0.0151
564 WEIGHT INCREASED 3369 0.0150
565 BONE DISORDER 273 0.0150
566 NEPHROPATHY TOXIC 168 0.0150
567 SKIN LESION 409 0.0149
568 HAEMOGLOBIN DECREASED 1530 0.0149
569 ANAEMIA 2838 0.0149
570 DYSARTHRIA 560 0.0149
571 SKIN HAEMORRHAGE 220 0.0148
572 EATING DISORDER 316 0.0148
573 INTERNAL HAEMORRHAGE 169 0.0148
574 HALLUCINATION, VISUAL 312 0.0148
575 JOINT RANGE OF MOTION DECREASED 198 0.0147
576 SHOCK 339 0.0147
577 SMALL INTESTINAL OBSTRUCTION 181 0.0147
578 QUALITY OF LIFE DECREASED 197 0.0147
579 COLON CANCER 218 0.0146
580 PRURITUS GENERALISED 316 0.0146
581 THERAPY CESSATION 750 0.0146
582 TRANSFUSION 153 0.0146
583 GASTRIC DISORDER 501 0.0146
584 HAEMATEMESIS 370 0.0146
585 PAIN 8962 0.0146
586 HAIR TEXTURE ABNORMAL 195 0.0146
587 HYPERCALCAEMIA 180 0.0146
588 RETINAL DETACHMENT 134 0.0146
589 GASTROENTERITIS VIRAL 263 0.0146
590 ELECTROLYTE IMBALANCE 169 0.0145
591 INTENTIONAL PRODUCT USE ISSUE 1271 0.0145
592 CYST 180 0.0145
593 DEPRESSION 3299 0.0145
594 WHITE BLOOD CELL COUNT INCREASED 554 0.0144
595 HYPERSOMNIA 413 0.0144
596 TOXIC SKIN ERUPTION 145 0.0144
597 SPINAL DISORDER 136 0.0143
598 OCULAR DISCOMFORT 161 0.0143
599 BLOOD LACTATE DEHYDROGENASE INCREASED 227 0.0143
600 MYOCARDITIS 164 0.0143
601 HYPERTENSIVE CRISIS 159 0.0143
602 INTENTIONAL DOSE OMISSION 407 0.0143
603 GINGIVAL BLEEDING 194 0.0142
604 HEPATIC CYTOLYSIS 181 0.0142
605 SINUS BRADYCARDIA 137 0.0142
606 INTESTINAL OBSTRUCTION 534 0.0142
607 COLD SWEAT 249 0.0141
608 PULMONARY HYPERTENSION 294 0.0141
609 LETHARGY 810 0.0141
610 HYPOCALCAEMIA 266 0.0140
611 FEEDING DISORDER 285 0.0140
612 HERPES ZOSTER 807 0.0140
613 MASS 196 0.0140
614 SLUGGISHNESS 143 0.0140
615 HEPATIC FUNCTION ABNORMAL 523 0.0140
616 KNEE ARTHROPLASTY 295 0.0140
617 JAUNDICE 377 0.0140
618 COLITIS 531 0.0140
619 ILEUS 174 0.0140
620 BLINDNESS UNILATERAL 197 0.0140
621 TREMOR 2318 0.0140
622 PRODUCT SUBSTITUTION ISSUE 804 0.0140
623 DISCOMFORT 852 0.0140
624 FLUID RETENTION 710 0.0139
625 ORAL CANDIDIASIS 183 0.0139
626 COVID-19 PNEUMONIA 164 0.0139
627 ORAL PAIN 311 0.0139
628 HOSPICE CARE 137 0.0139
629 CHOKING 270 0.0138
630 ERYTHEMA MULTIFORME 129 0.0138
631 DISORIENTATION 548 0.0138
632 SKIN DISCOLOURATION 635 0.0138
633 ACCIDENT 165 0.0138
634 HIP ARTHROPLASTY 211 0.0138
635 SENSORY DISTURBANCE 221 0.0138
636 RASH PRURITIC 746 0.0138
637 BLOOD GLUCOSE DECREASED 660 0.0137
638 NAUSEA 10873 0.0137
639 VOMITING 6426 0.0137
640 SPINAL OPERATION 168 0.0136
641 HEPATOMEGALY 134 0.0136
642 INJECTION SITE NODULE 150 0.0136
643 PRURITUS 5232 0.0136
644 DELIRIUM 472 0.0136
645 LOSS OF CONSCIOUSNESS 1739 0.0136
646 DYSPHAGIA 1288 0.0136
647 PAIN IN JAW 384 0.0135
648 DRUG ERUPTION 240 0.0135
649 LEUKOCYTOSIS 245 0.0135
650 RASH MACULO-PAPULAR 301 0.0135
651 INCONTINENCE 143 0.0135
652 HEADACHE 8466 0.0135
653 FEELING JITTERY 257 0.0135
654 EYE IRRITATION 776 0.0135
655 PALLOR 366 0.0134
656 DRY EYE 671 0.0134
657 EYE PAIN 755 0.0134
658 SCRATCH 141 0.0134
659 FEELING ABNORMAL 3201 0.0133
660 INSURANCE ISSUE 204 0.0133
661 HIP FRACTURE 429 0.0133
662 PHARYNGEAL SWELLING 130 0.0133
663 INFUSION SITE PAIN 171 0.0133
664 DRUG LEVEL INCREASED 218 0.0132
665 VISION BLURRED 1803 0.0131
666 SPEECH DISORDER 688 0.0131
667 PNEUMONIA ASPIRATION 328 0.0131
668 HALLUCINATION 989 0.0131
669 IMPAIRED DRIVING ABILITY 149 0.0131
670 DENTAL CARIES 145 0.0131
671 LYMPHADENOPATHY 464 0.0131
672 SKIN DISORDER 437 0.0131
673 BEDRIDDEN 172 0.0131
674 NERVOUSNESS 683 0.0131
675 ILL-DEFINED DISORDER 794 0.0131
676 PULMONARY EMBOLISM 1241 0.0130
677 ORAL DISCOMFORT 181 0.0130
678 SARS-COV-2 TEST POSITIVE 172 0.0130
679 LYMPHOCYTE COUNT DECREASED 230 0.0130
680 SKIN CANCER 280 0.0130
681 CHILLS 1523 0.0130
682 RETCHING 277 0.0130
683 RASH PAPULAR 291 0.0130
684 ROAD TRAFFIC ACCIDENT 543 0.0130
685 THROMBOSIS 1044 0.0130
686 DEEP VEIN THROMBOSIS 842 0.0129
687 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 133 0.0129
688 TOOTH DISORDER 288 0.0129
689 KIDNEY INFECTION 254 0.0129
690 PARALYSIS 185 0.0129
691 LABORATORY TEST ABNORMAL 381 0.0129
692 HUNGER 179 0.0128
693 ANOSMIA 186 0.0128
694 MUSCLE TWITCHING 296 0.0128
695 HAEMORRHAGE INTRACRANIAL 192 0.0128
696 IRRITABLE BOWEL SYNDROME 275 0.0128
697 ULCER 204 0.0128
698 INFLUENZA LIKE ILLNESS 1055 0.0128
699 HYPOAESTHESIA ORAL 193 0.0128
700 GASTROINTESTINAL DISORDER 1143 0.0127
701 DIALYSIS 181 0.0127
702 CANDIDA INFECTION 215 0.0127
703 DEPRESSED MOOD 673 0.0127
704 HYPOACUSIS 548 0.0127
705 DISTURBANCE IN ATTENTION 686 0.0127
706 MUSCULOSKELETAL DISORDER 242 0.0127
707 THROAT IRRITATION 570 0.0127
708 DEAFNESS 332 0.0127
709 ALTERED STATE OF CONSCIOUSNESS 275 0.0127
710 GASTRIC HAEMORRHAGE 146 0.0127
711 LOWER RESPIRATORY TRACT INFECTION 576 0.0127
712 PRODUCT TASTE ABNORMAL 171 0.0126
713 NEOPLASM 145 0.0126
714 MIGRAINE 1203 0.0126
715 SWELLING 1178 0.0126
716 PULMONARY THROMBOSIS 137 0.0126
717 ANXIETY 3575 0.0125
718 LOWER LIMB FRACTURE 241 0.0125
719 ADRENAL INSUFFICIENCY 152 0.0125
720 PLATELET COUNT DECREASED 1335 0.0125
721 ALOPECIA 2458 0.0125
722 EYE PRURITUS 420 0.0125
723 POST PROCEDURAL COMPLICATION 240 0.0125
724 BLOOD BILIRUBIN INCREASED 337 0.0125
725 BODY TEMPERATURE INCREASED 253 0.0124
726 RHEUMATOID ARTHRITIS 1405 0.0124
727 ANGIOEDEMA 547 0.0124
728 BRONCHOSPASM 176 0.0123
729 EYE DISORDER 405 0.0123
730 THROAT TIGHTNESS 332 0.0123
731 LOCAL SWELLING 214 0.0123
732 PSORIATIC ARTHROPATHY 497 0.0122
733 RASH MACULAR 428 0.0122
734 PARANOIA 211 0.0122
735 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 870 0.0122
736 BACTERAEMIA 145 0.0122
737 VISUAL IMPAIRMENT 1514 0.0122
738 EYE SWELLING 454 0.0122
739 VIRAL INFECTION 406 0.0122
740 DERMATITIS CONTACT 139 0.0122
741 SOMNOLENCE 2437 0.0121
742 PHARYNGEAL OEDEMA 186 0.0121
743 TOOTH EXTRACTION 150 0.0120
744 ORAL HERPES 235 0.0120
745 VISUAL ACUITY REDUCED 399 0.0120
746 SWELLING FACE 781 0.0120
747 ATAXIA 142 0.0120
748 MUSCLE SPASTICITY 147 0.0120
749 PRODUCT PHYSICAL ISSUE 240 0.0119
750 INCREASED APPETITE 227 0.0119
751 SEPSIS 1322 0.0118
752 FULL BLOOD COUNT DECREASED 238 0.0118
753 FACE OEDEMA 199 0.0118
754 FUNGAL INFECTION 392 0.0117
755 PRODUCT DOSE OMISSION IN ERROR 333 0.0117
756 GENERAL PHYSICAL HEALTH DETERIORATION 1355 0.0117
757 ACCIDENTAL OVERDOSE 428 0.0117
758 CONDITION AGGRAVATED 3557 0.0117
759 INFLAMMATION 603 0.0117
760 PYREXIA 4030 0.0116
761 GALLBLADDER DISORDER 207 0.0116
762 SKIN INFECTION 130 0.0116
763 MADAROSIS 134 0.0115
764 PHOTOPHOBIA 217 0.0115
765 TACHYCARDIA 1023 0.0115
766 PRESCRIBED UNDERDOSE 229 0.0115
767 SEPTIC SHOCK 498 0.0114
768 OSTEOMYELITIS 207 0.0114
769 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2060 0.0114
770 THERAPY INTERRUPTED 808 0.0113
771 EAR INFECTION 299 0.0112
772 TACHYPNOEA 152 0.0112
773 BLISTER 627 0.0112
774 IMMUNE SYSTEM DISORDER 147 0.0111
775 ECZEMA 583 0.0111
776 RESPIRATORY FAILURE 812 0.0111
777 ERYTHEMA 2282 0.0111
778 MENTAL IMPAIRMENT 269 0.0111
779 THERAPEUTIC RESPONSE UNEXPECTED 496 0.0110
780 PNEUMONITIS 301 0.0110
781 COAGULOPATHY 184 0.0110
782 WRONG TECHNIQUE IN DRUG USAGE PROCESS 401 0.0110
783 SPLENOMEGALY 129 0.0110
784 HEPATOTOXICITY 245 0.0110
785 THINKING ABNORMAL 205 0.0110
786 CARDIAC ARREST 907 0.0110
787 IMMUNODEFICIENCY 163 0.0109
788 PSORIASIS 1428 0.0109
789 DYSKINESIA 444 0.0109
790 MOUTH ULCERATION 230 0.0109
791 ILLNESS 1121 0.0109
792 DELUSION 169 0.0109
793 SCAR 186 0.0109
794 ELECTROCARDIOGRAM QT PROLONGED 390 0.0108
795 PANIC ATTACK 395 0.0108
796 RASH 4719 0.0108
797 MYOCLONUS 129 0.0108
798 LUNG INFECTION 167 0.0107
799 RESTLESSNESS 393 0.0107
800 DERMATITIS ALLERGIC 135 0.0107
801 OCULAR HYPERAEMIA 509 0.0107
802 DEVICE OCCLUSION 150 0.0106
803 HEPATIC CIRRHOSIS 200 0.0106
804 RESPIRATORY DISORDER 318 0.0106
805 STAPHYLOCOCCAL INFECTION 350 0.0106
806 OFF LABEL USE 9289 0.0106
807 ADVERSE DRUG REACTION 952 0.0106
808 AGRANULOCYTOSIS 197 0.0106
809 DRUG PRESCRIBING ERROR 201 0.0105
810 APATHY 152 0.0104
811 STOMATITIS 632 0.0104
812 PERICARDITIS 175 0.0104
813 MULTIPLE ORGAN DYSFUNCTION SYNDROME 295 0.0104
814 BACTERIAL INFECTION 194 0.0104
815 DRUG EFFECT LESS THAN EXPECTED 154 0.0104
816 RASH GENERALISED 269 0.0104
817 THROMBOCYTOPENIA 1160 0.0104
818 MULTIPLE FRACTURES 169 0.0103
819 WOUND 287 0.0103
820 URTICARIA 1720 0.0103
821 ANOREXIA 132 0.0102
822 PANCYTOPENIA 571 0.0102
823 CIRCULATORY COLLAPSE 174 0.0102
824 BLINDNESS 416 0.0102
825 INFUSION RELATED REACTION 676 0.0102
826 RESPIRATORY DISTRESS 281 0.0102
827 CONTRAINDICATED PRODUCT ADMINISTERED 308 0.0102
828 HAEMORRHAGE 1060 0.0101
829 IMPAIRED HEALING 332 0.0101
830 LYMPHOMA 156 0.0101
831 SKIN EXFOLIATION 850 0.0101
832 METASTASES TO LIVER 177 0.0101
833 MEDICATION ERROR 557 0.0100
834 ANAPHYLACTIC SHOCK 258 0.0100
835 LUNG NEOPLASM MALIGNANT 411 0.0100
836 NEEDLE ISSUE 289 0.0099
837 UNRESPONSIVE TO STIMULI 256 0.0099
838 SURGERY 580 0.0099
839 PULMONARY ARTERIAL HYPERTENSION 143 0.0099
840 PRODUCT PRESCRIBING ERROR 235 0.0099
841 SINUS TACHYCARDIA 140 0.0098
842 ABSCESS 157 0.0098
843 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 252 0.0098
844 HYPERSENSITIVITY 1817 0.0098
845 TREATMENT NONCOMPLIANCE 535 0.0098
846 RASH ERYTHEMATOUS 466 0.0097
847 ANKYLOSING SPONDYLITIS 128 0.0097
848 PRODUCT USE COMPLAINT 153 0.0097
849 PAIN OF SKIN 261 0.0097
850 ADVERSE EVENT 892 0.0097
851 PRODUCT ADMINISTRATION ERROR 194 0.0096
852 WHITE BLOOD CELL COUNT DECREASED 1034 0.0095
853 DISSEMINATED INTRAVASCULAR COAGULATION 134 0.0095
854 FEMUR FRACTURE 294 0.0095
855 MENTAL STATUS CHANGES 262 0.0094
856 MOOD ALTERED 253 0.0093
857 ENCEPHALOPATHY 226 0.0092
858 METASTASES TO BONE 150 0.0091
859 INFECTION 1319 0.0091
860 AGITATION 664 0.0090
861 HALLUCINATION, AUDITORY 143 0.0090
862 PRODUCT DOSE OMISSION ISSUE 2619 0.0089
863 SYSTEMIC LUPUS ERYTHEMATOSUS 315 0.0089
864 SKIN FISSURES 173 0.0088
865 FEAR 238 0.0088
866 IRRITABILITY 532 0.0088
867 HEPATIC FAILURE 266 0.0088
868 DERMATITIS 184 0.0088
869 NEOPLASM MALIGNANT 586 0.0088
870 GLOSSODYNIA 196 0.0087
871 SEROTONIN SYNDROME 167 0.0087
872 INJECTION SITE MASS 320 0.0086
873 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 615 0.0086
874 ANGER 291 0.0086
875 CARDIO-RESPIRATORY ARREST 359 0.0086
876 PRESCRIBED OVERDOSE 166 0.0086
877 CYANOSIS 134 0.0085
878 ANAPHYLACTIC REACTION 469 0.0085
879 PROCEDURAL PAIN 235 0.0085
880 PRODUCT USE ISSUE 1588 0.0084
881 MULTI-ORGAN FAILURE 145 0.0084
882 PELVIC PAIN 151 0.0083
883 FRACTURE 157 0.0083
884 PRODUCT AVAILABILITY ISSUE 188 0.0082
885 DISABILITY 163 0.0082
886 THERAPEUTIC RESPONSE SHORTENED 272 0.0082
887 PRODUCT USE IN UNAPPROVED INDICATION 2032 0.0082
888 MENTAL DISORDER 353 0.0081
889 DRY SKIN 1074 0.0080
890 ASCITES 234 0.0080
891 CYTOKINE RELEASE SYNDROME 159 0.0079
892 DRUG EFFECT INCOMPLETE 284 0.0078
893 CRYING 284 0.0078
894 BONE DENSITY DECREASED 240 0.0077
895 INJECTION SITE HAEMORRHAGE 609 0.0076
896 UNDERDOSE 556 0.0076
897 SUICIDAL IDEATION 697 0.0076
898 DRUG INEFFECTIVE 9957 0.0075
899 NEUTROPHIL COUNT DECREASED 307 0.0075
900 PSYCHOTIC DISORDER 222 0.0075
901 UNEVALUABLE EVENT 562 0.0074
902 STEVENS-JOHNSON SYNDROME 164 0.0074
903 PRODUCT DOSE OMISSION 481 0.0074
904 ACUTE RESPIRATORY DISTRESS SYNDROME 130 0.0073
905 THERAPY NON-RESPONDER 328 0.0073
906 MOOD SWINGS 232 0.0073
907 COMA 345 0.0072
908 MALIGNANT NEOPLASM PROGRESSION 741 0.0072
909 CONJUNCTIVITIS 134 0.0072
910 MUCOSAL INFLAMMATION 189 0.0072
911 LEUKOPENIA 361 0.0072
912 TOOTH LOSS 149 0.0072
913 NEUTROPENIA 975 0.0072
914 AGGRESSION 353 0.0070
915 INCORRECT DOSE ADMINISTERED 1609 0.0070
916 EXPIRED PRODUCT ADMINISTERED 234 0.0070
917 INJURY 494 0.0070
918 SKIN BURNING SENSATION 490 0.0068
919 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 159 0.0068
920 TOXICITY TO VARIOUS AGENTS 1145 0.0068
921 OSTEONECROSIS 223 0.0068
922 SEIZURE 780 0.0067
923 INCORRECT PRODUCT ADMINISTRATION DURATION 146 0.0067
924 NERVOUS SYSTEM DISORDER 209 0.0067
925 INJECTION SITE BRUISING 531 0.0066
926 THERAPEUTIC PRODUCT EFFECT DECREASED 298 0.0066
927 EMOTIONAL DISORDER 205 0.0066
928 EMOTIONAL DISTRESS 799 0.0066
929 PANCREATIC CARCINOMA 188 0.0065
930 DISEASE PROGRESSION 756 0.0064
931 DRUG ADMINISTRATION ERROR 195 0.0063
932 PRODUCT PRESCRIBING ISSUE 138 0.0063
933 HOSPITALISATION 968 0.0063
934 INJECTION SITE PRURITUS 419 0.0062
935 PLASMA CELL MYELOMA 244 0.0062
936 PRODUCT QUALITY ISSUE 838 0.0062
937 DEVICE MALFUNCTION 432 0.0061
938 OSTEONECROSIS OF JAW 152 0.0061
939 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 337 0.0061
940 APPLICATION SITE PRURITUS 137 0.0060
941 THERAPEUTIC RESPONSE DECREASED 366 0.0060
942 DRUG RESISTANCE 154 0.0060
943 DRUG EFFECT DECREASED 321 0.0060
944 INJECTION SITE PAIN 1827 0.0060
945 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1177 0.0058
946 CONVULSION 332 0.0058
947 NEOPLASM PROGRESSION 198 0.0057
948 APPLICATION SITE ERYTHEMA 149 0.0057
949 ABNORMAL BEHAVIOUR 224 0.0056
950 MULTIPLE SCLEROSIS 269 0.0056
951 GYNAECOMASTIA 174 0.0056
952 INCORRECT DRUG ADMINISTRATION DURATION 153 0.0054
953 DEATH 4557 0.0053
954 BREAST CANCER 488 0.0052
955 INJECTION SITE ERYTHEMA 646 0.0052
956 EPILEPSY 159 0.0052
957 DEVICE ISSUE 463 0.0052
958 INJECTION SITE SWELLING 390 0.0051
959 DEVICE DELIVERY SYSTEM ISSUE 138 0.0050
960 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 170 0.0050
961 SKIN IRRITATION 229 0.0050
962 INCORRECT DOSE ADMINISTERED BY DEVICE 131 0.0050
963 BREAST CANCER FEMALE 131 0.0049
964 ACNE 371 0.0049
965 PROSTATE CANCER 390 0.0048
966 WITHDRAWAL SYNDROME 202 0.0048
967 RESPIRATORY ARREST 132 0.0048
968 INJECTION SITE RASH 145 0.0047
969 EXTRA DOSE ADMINISTERED 187 0.0046
970 SUICIDE ATTEMPT 270 0.0044
971 DERMATITIS ATOPIC 232 0.0044
972 INJECTION SITE REACTION 302 0.0044
973 TREATMENT FAILURE 348 0.0042
974 MULTIPLE SCLEROSIS RELAPSE 285 0.0042
975 DEVICE LEAKAGE 179 0.0041
976 VAGINAL HAEMORRHAGE 178 0.0041
977 OVERDOSE 871 0.0040
978 INTENTIONAL OVERDOSE 249 0.0039
979 PRODUCT ADHESION ISSUE 138 0.0039
980 ACCIDENTAL EXPOSURE TO PRODUCT 393 0.0038
981 BLADDER CANCER 215 0.0036
982 COMPLETED SUICIDE 284 0.0034
983 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 156 0.0033
984 DEVICE DISLOCATION 142 0.0033
985 NO ADVERSE EVENT 562 0.0031
986 DRUG DOSE OMISSION BY DEVICE 223 0.0028
987 RENAL CANCER 135 0.0028
988 DRUG WITHDRAWAL SYNDROME 246 0.0028
989 PRODUCT STORAGE ERROR 245 0.0028
990 DEVICE DIFFICULT TO USE 175 0.0026
991 DRUG ABUSE 188 0.0023
992 DRUG DEPENDENCE 174 0.0011